Edition:
India

Aethlon Medical Inc (AEMD.OQ)

AEMD.OQ on NASDAQ Stock Exchange Capital Market

0.80USD
1:30am IST
Change (% chg)

$0.05 (+5.94%)
Prev Close
$0.76
Open
$0.77
Day's High
$0.85
Day's Low
$0.72
Volume
46,145
Avg. Vol
21,581
52-wk High
$1.74
52-wk Low
$0.65

Latest Key Developments (Source: Significant Developments)

Aethlon Medical Says Working On Executing Plan To Advance Co's Unique Hemopurifier Through Clinical Trials & Regulatory Approvals
Wednesday, 17 Apr 2019 

April 17 (Reuters) - Aethlon Medical Inc ::AETHLON MEDICAL INC - WORKING ON EXECUTING A PLAN TO ADVANCE AETHLON'S UNIQUE HEMOPURIFIER THROUGH CLINICAL TRIALS AND REGULATORY APPROVALS.AETHLON MEDICAL - TO FOCUS PRIMARY DEVELOPMENT EFFORTS IN CANCER WHERE EXOSOMES CAN BE REMOVED BY HEMOPURIFIER .AETHLON MEDICAL INC - NOW COMMUNICATING WITH FDA AND PREPARING FOR CLINICAL TRIALS IN CANCER.  Full Article

Aethlon Medical Inc says Effective Nov 30, Rod Kenley Was Terminated As President Of Co
Saturday, 8 Dec 2018 

Dec 7 (Reuters) - Aethlon Medical Inc ::AETHLON MEDICAL INC - EFFECTIVE NOVEMBER 30, 2018, ROD KENLEY WAS TERMINATED AS PRESIDENT OF CO - SEC FILING.AETHLON MEDICAL INC - ALSO DETERMINED TO NOT NOMINATE KENLEY TO STAND FOR REELECTION AS DIRECTOR AT CO'S ANNUAL MEETING TO BE HELD IN MARCH 2019.  Full Article

Aethlon Medical Participates In Informational Meeting With FDA​
Thursday, 22 Mar 2018 

March 21 (Reuters) - Aethlon Medical Inc ::AETHLON MEDICAL SAYS ‍ON MARCH 20, CO PARTICIPATED IN AN INFORMATIONAL MEETING WITH FDA​ - SEC FILING.AETHLON - FDA ‍MEETING RESULT OF FORMAL PRE-SUBMISSION REQUEST BY CO FOR DISCUSSING ADVANCEMENT OF AETHLON HEMOPURIFIER (REG) UNDER EAP.  Full Article

Aethlon Medical Announces Fiscal 2018 Third Quarter Results
Friday, 2 Feb 2018 

Feb 1 (Reuters) - Aethlon Medical Inc ::AETHLON MEDICAL ANNOUNCES FISCAL 2018 THIRD QUARTER RESULTS.Q3 LOSS PER SHARE $0.08.  Full Article

Aethlon Medical announces second quarter results
Friday, 3 Nov 2017 

Nov 2 (Reuters) - Aethlon Medical Inc :Aethlon Medical announces fiscal 2018 second quarter results.Q2 loss per share $0.14.  Full Article

AETHLON MEDICAL ANNOUNCES PRODUCTION COLLABORATION WITH IBIO INC
Monday, 16 Oct 2017 

Oct 16 (Reuters) - Aethlon Medical Inc ::AETHLON MEDICAL ANNOUNCES LARGE-SCALE PRODUCTION COLLABORATION.AETHLON MEDICAL INC - HAS ESTABLISHED A COLLABORATION WITH IBIO INC. TO SUPPORT POTENTIAL LARGE-SCALE PRODUCTION OF AETHLON HEMOPURIFIER​.  Full Article

IBIO ANNOUNCES MANUFACTURING COLLABORATION WITH AETHLON MEDICAL
Monday, 16 Oct 2017 

Oct 16 (Reuters) - iBio Inc ::IBIO ANNOUNCES MANUFACTURING COLLABORATION WITH AETHLON MEDICAL.IBIO INC - ‍AGREEMENT WITH AETHLON MEDICAL INC TO SUPPORT POTENTIAL LARGE-SCALE PRODUCTION OF AETHLON HEMOPURIFIER BLOOD PURIFICATION DEVICE​.  Full Article

Intracoastal Capital reports 5.7 pct passive stake in Aethlon Medical
Thursday, 12 Oct 2017 

Oct 11 (Reuters) - Aethlon Medical Inc :Intracoastal Capital LLC reports 5.7 percent passive stake in Aethlon Medical Inc as of Oct 2 - SEC filing‍​.  Full Article

Aethlon Medical received formal receipt from FDA for expedited access pathway program submission ‍​
Tuesday, 15 Aug 2017 

Aug 14 (Reuters) - Aethlon Medical Inc ::On Aug 14, co received formal receipt from the U.S. FDA for expedited access pathway program submission ‍​.Submission formally requests that the Aethlon Hemopurifier be included in the FDA EAP program - SEC filing‍​.  Full Article

Aethlon Medical reports Q1 loss per share $0.21
Friday, 11 Aug 2017 

Aug 10 (Reuters) - Aethlon Medical Inc -:Aethlon Medical announces fiscal 2018 first quarter results.Q1 loss per share $0.21.Aethlon Medical - ‍finalized expedited access pathway program submission that its regulatory advisors will provide to united states FDA.Aethlon Medical Inc - ‍finalized submission requests that aethlon hemopurifier be included in eap program​.  Full Article